Gelteq Ltd revenue

Gelteq Ltd's revenue was $107,317 in fiscal 2025, up 99.7% on the year before.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Gelteq Ltd: revenue history, annual
Fiscal year	2023Jun 2023	2025Jun 2025
Revenue	54	107
Growth on the year before	—	+99.7%
Gross profit	—	33
Gross margin	—	30.3%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Gelteq Ltd	$107,317	—	—
Akanda Corp.	$258,075	-69.2%	—
PRF Technologies Ltd.	$17,000	—	—
Scienture Holdings, Inc.	$821,315	540.6%	-58.5%
60 Degrees Pharmaceuticals, Inc.	$1.1m	73.2%	74.9%
China SXT Pharmaceuticals, Inc.	$1.1m	-34.6%	—

Compare with peers

Head to head: AKAN vs GELS GELS vs PRFX GELS vs SCNX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Gelteq Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Gelteq Ltd.